Invention Grant
- Patent Title: Serum albumin binding proteins containing immunoglobulin single variable domains
-
Application No.: US15615281Application Date: 2017-06-06
-
Publication No.: US11192938B2Publication Date: 2021-12-07
- Inventor: Judith Baumeister , Marie-Paule Lucienne Armanda Bouche , Carlo Boutton , Marie-Ange Buyse , Veerle Snoeck , Stephanie Staelens , Bruno Dombrecht , Peter Schotte , Cedric Jozef Neotere Ververken , Gerald Beste , Guy Hermans , Soren Steffensen , Alexander Szyroki , Tinneke Denayer
- Applicant: Ablynx N. V.
- Applicant Address: BE Zwijnaarde
- Assignee: Ablynx N. V.
- Current Assignee: Ablynx N. V.
- Current Assignee Address: BE Zwijnaarde
- Agency: Wolf, Greenfield & Sacks, P.C.
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C07K16/18 ; A61K39/00 ; A61K39/395 ; C07K16/28 ; C07K16/42 ; G01N33/53 ; G01N33/543 ; G01N33/68

Abstract:
This invention provides, and in certain specific but non-limiting aspects relates to: assays that can be used to predict whether a given ISV will be subject to protein interference and/or give rise to an (aspecific) signal in such an assay (such as in an ADA immunoassay; methods for modifying and/or improving ISV's to as to remove or reduce their tendency to give rise to such protein interference or such a signal; modifications that can be introduced into an ISV that remove or reduce its tendency to give rise to such protein interference or such a signal; ISV's that have been specifically selected (for example, using the assay(s) described herein) to have no or low(er)/reduced tendency to give rise to such protein interference or such a signal; modified and/or improved ISV's that have no or a low(er)/reduced tendency to give rise to such protein interference or such a signal.
Public/Granted literature
Information query